# Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

> **NCT00005886** · PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** arzoxifene hydrochloride
- **DRUG:** tamoxifen citrate

## Key facts

- **NCT ID:** NCT00005886
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** — (—)
- **Last updated:** 2017-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005886, "Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*